<DOC>
	<DOCNO>NCT01897805</DOCNO>
	<brief_summary>Title : A randomized , double-blind , multi-centered , placebo-controlled trial examine effect Heart-protecting Musk Pill clinical outcome patient chronic stable coronary artery disease Objective : To examine effect Heart-protecting Musk Pill , traditional Chinese medicine , clinical outcome patient chronic stable coronary artery disease The study hypothesis : The null hypothesis : combine incidence cardiovascular death , nonfatal myocardial infarction , nonfatal stroke treatment group control group . The alternative hypothesis : combine incidence cardiovascular death , nonfatal myocardial infarction , nonfatal stroke treatment group different control group . Sample size : 2700 patient randomize , 1350 treatment group 1350 placebo group . Number sit : 99 site China Study drug : Heart-protecting Musk Pill match placebo pill . Design : A randomized , double-blind , multi-centered , placebo-controlled trial . Patients randomized treatment group placebo group screen get corresponding treatment follow . Treatment group : Standard treatment coronary artery disease plus 2 Heart-protecting Musk Pills time , three time day mouth 24 month . Control group : Standard treatment coronary artery disease plus 2 placebo pill time , three time day mouth 24 month . Patients follow baseline , 1 , 3 , 6 , 9 , 12 , 18 , 24 month randomization . During follow-up period , patient could undertake PCI CABG angina get control evidence ischemia aggravate found .</brief_summary>
	<brief_title>A Trial Evaluate Efficacy Heart-protecting Musk Pill</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Age≥18 year screen . 2 . Patients ischemia myocardial symptom whose clinical symptom keep stable least one month . 3 . Have least one follow event ( provide hospital record inspection report ) : 1 ) history acute myocardial infarction least half year ; 2 ) history PCI CABG least half year ; 3 ) coronary CT angiography coronary angiography show least one main branch coronary artery stenosis le 50 % . 4 . Provide informed consent form . 1 . History acute myocardial infarction , vascular reconstruction , CABG PCI within half year . 2 . Prepared undertake CABG PCI study . 3 . Serious cardiovascular disease : sustain severe angina ( CCS Ⅳ ) , refractory heart failure , cardiogenic shock , severe aortic stenosis aortic insufficiency . 4 . Severe respiratory disease ; 5 . Diabetic patient poor glycemic control ( fast blood glucose &gt; 200 mg/dl 11.1mmol/L twice within one month study entry ) . 6 . Hypertensive patient poor control blood pressure , systolic pressure≥180mmHg diastolic pressure≥110mmHg entry . 7 . Severe liver kidney disease , active liver disease , cirrhosis uremia . 8 . Any severe disease , malignant tumor , severe anemia severe renal artery stenosis . 9 . Unable unwilling sign inform consent form . 10 . Join another trial receive random allocation study within one month entry . 11 . Pregnant attempt become pregnant . 12 . Patients regard suitable participant study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Coronary artery disease</keyword>
</DOC>